首页> 外文期刊>Clinical & translational oncology : >Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
【24h】

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

机译:代表西班牙内分泌学会甲状腺癌工作组(SEEN)和西班牙孤儿和少见肿瘤工作组(GETHI)进行的晚期甲状腺髓样癌的治疗共识

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Of all thyroid cancers, < 5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays a central role on its pathogeny.
机译:在所有甲状腺癌中,<5%是髓样(MTC)。它是由降钙素分泌的C细胞引起的特征明确的神经内分泌肿瘤,RET基因在其致病性中起着核心作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号